BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27732956)

  • 21. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
    Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.
    Bagrodia A; Lee BH; Lee W; Cha EK; Sfakianos JP; Iyer G; Pietzak EJ; Gao SP; Zabor EC; Ostrovnaya I; Kaffenberger SD; Syed A; Arcila ME; Chaganti RS; Kundra R; Eng J; Hreiki J; Vacic V; Arora K; Oschwald DM; Berger MF; Bajorin DF; Bains MS; Schultz N; Reuter VE; Sheinfeld J; Bosl GJ; Al-Ahmadie HA; Solit DB; Feldman DR
    J Clin Oncol; 2016 Nov; 34(33):4000-4007. PubMed ID: 27646943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors.
    Seidel C; Daugaard G; Tryakin A; Necchi A; Cohn Cedermark G; Ståhl O; Hentrich M; Brito M; Albany C; Taza F; Gerl A; Oechsle K; Bokemeyer C
    Eur J Cancer; 2018 May; 94():16-25. PubMed ID: 29505967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolic events in germ cell cancer patients undergoing platinum-based chemotherapy.
    Honecker F; Koychev D; Luhmann AD; Langer F; Dieckmann KP; Bokemeyer C; Oechsle K
    Onkologie; 2013; 36(11):663-8. PubMed ID: 24192771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
    Kalavska K; Sestakova Z; Mlcakova A; Kozics K; Gronesova P; Hurbanova L; Miskovska V; Rejlekova K; Svetlovska D; Sycova-Mila Z; Obertova J; Palacka P; Mardiak J; Chovanec M; Chovanec M; Mego M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort.
    Wessalowski R; Blohm M; Calaminus G; Engert J; Harms D; Krause I; Kruck H; Grüttner HP; Pape H; Göbel U
    Klin Padiatr; 1997; 209(4):250-6. PubMed ID: 9293458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.
    Pectasides D; Papaxoinis G; Nikolaou M; Valavanis C; Aravantinos G; Fountzilas G; Tamvakis N; Pectasides E; Lekka I; Arapantoni-Dadioti P; Zizi A; Ghiconti I; Economopoulos T
    Anticancer Res; 2009 Feb; 29(2):737-44. PubMed ID: 19331230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a risk stratification system to guide treatment for female germ cell tumors.
    Meisel JL; Woo KM; Sudarsan N; Eng J; Patil S; Jacobsen EP; Murali R; Gardner GJ; Bosl GJ; Aghajanian C; Feldman DR
    Gynecol Oncol; 2015 Sep; 138(3):566-72. PubMed ID: 26115974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer.
    Sánchez-Suárez P; Ostrosky-Wegman P; Gallegos-Hernández F; Peñarroja-Flores R; Toledo-García J; Bravo JL; Del Castillo ER; Benítez-Bribiesca L
    Mutat Res; 2008 Apr; 640(1-2):8-15. PubMed ID: 18207203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
    Faure-Conter C; Orbach D; Cropet C; Baranzelli MC; Martelli H; Thebaud E; Vérité C; Rome A; Fasola S; Corradini N; Rocourt N; Frappaz D; Kalfa N; Patte C
    Pediatr Blood Cancer; 2014 Feb; 61(2):253-9. PubMed ID: 23940114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of ERCC1 expression in peripheral blood lymphocytes with outcomes of patients with gastric cancer treated with oxaliplatin-based adjuvant chemotherapy.
    Zhang YY; Gu KS; Wu HY; Yang F; Bu LJ; Zhao CC; Zhang YR
    Genet Mol Res; 2015 Dec; 14(4):15921-9. PubMed ID: 26662383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of primary malignant germ cell tumor of the mediastinum.
    Sakurai H; Asamura H; Suzuki K; Watanabe S; Tsuchiya R
    Jpn J Clin Oncol; 2004 Jul; 34(7):386-92. PubMed ID: 15342665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
    Chovanec M; Cierna Z; Miskovska V; Machalekova K; Svetlovska D; Kalavska K; Rejlekova K; Spanik S; Kajo K; Babal P; Mardiak J; Mego M
    Oncotarget; 2017 Mar; 8(13):21794-21805. PubMed ID: 28423520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA damage in tumor cells and peripheral blood lymphocytes of endometrial cancer patients assessed by the comet assay.
    Buchynska LG; Brieieva OV; Iurchenko NP; Protsenko VV; Nespryadko SV
    Exp Oncol; 2017 Dec; 39(4):299-303. PubMed ID: 29284781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
    Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
    Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
    Kesler KA; Rieger KM; Hammoud ZT; Kruter LE; Perkins SM; Turrentine MW; Schneider BP; Einhorn LH; Brown JW
    Ann Thorac Surg; 2008 Feb; 85(2):371-8. PubMed ID: 18222228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
    Malagón HD; Valdez AM; Moran CA; Suster S
    Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.